Indication
Macular Edema following Retinal Vein Occlusion
Macular edema following retinal vein occlusion is a sight-threatening ophthalmic complication characterized by intraretinal fluid accumulation within the macula, the central region of the retina responsible for sharp, high-acuity vision. Read more about Macular Edema following Retinal Vein Occlusion
5 drugs 5 manufacturers
Drugs that treat it
Common Macular Edema following Retinal Vein Occlusion therapies.
VABYSMO (faricimab-svoa)
PAVBLU (aflibercept-ayyh)
YESAFILI (aflibercept-jbvf)
ENZEEVU (aflibercept-abzv)
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonMacular edema following retinal vein occlusion is a sight-threatening ophthalmic complication characterized by intraretinal fluid accumulation within the macula, the central region of the retina responsible for sharp, high-acuity vision.
It occurs in patients following an obstruction in the retinal venous circulation, categorized as either branch retinal vein occlusion (BRVO) or central retinal vein occlusion (CRVO).
The condition is pathophysiologically driven by intraluminal thrombosis, elevated capillary hydrostatic pressure, retinal ischemia, and subsequent upregulation of inflammatory cytokines and vascular endothelial growth factor (VEGF).
These mechanisms disrupt the inner blood-retinal barrier, causing vascular hyperpermeability, exudation, retinal thickening, and progressive loss of central visual acuity.
- nih.gov
Macular edema following retinal vein occlusion is a sight-threatening ophthalmic complication characterized by intraretinal fluid accumulation within the macula, the central region of the retina responsible for sharp, high-acuity vision These mechanisms disrupt the inner blood-retinal barrier, causing vascular hyperpermeability, exudation, retinal thickening, and progressive loss of central visual acuity
- nih.gov
Macular edema following retinal vein occlusion is a sight-threatening ophthalmic complication characterized by intraretinal fluid accumulation within the macula, the central region of the retina responsible for sharp, high-acuity vision The condition is pathophysiologically driven by intraluminal thrombosis, elevated capillary hydrostatic pressure, retinal ischemia, and subsequent upregulation of inflammatory cytokines and vascular endothelial growth factor (VEGF)
- nih.gov
It occurs in patients following an obstruction in the retinal venous circulation, categorized as either branch retinal vein occlusion (BRVO) or central retinal vein occlusion (CRVO) The condition is pathophysiologically driven by intraluminal thrombosis, elevated capillary hydrostatic pressure, retinal ischemia, and subsequent upregulation of inflammatory cytokines and vascular endothelial growth factor (VEGF) These mechanisms disrupt the inner blood-retinal barrier, causing vascular hyperpermea...
- nih.gov
It occurs in patients following an obstruction in the retinal venous circulation, categorized as either branch retinal vein occlusion (BRVO) or central retinal vein occlusion (CRVO)
Personalize your experience
Follow Macular Edema following Retinal Vein Occlusion and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.